Recent News

• 11.14.2025 - Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
• 11.14.2025 - Tivic Reports Third Quarter 2025 Financial Results
• 11.06.2025 - Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast
• 10.22.2025 - Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23
• 09.22.2025 - Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference
• 09.10.2025 - Tivic Completes Verification of Entolimod™ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

Recent Filings

• 11.13.2025 - 8-K Current report
• 11.13.2025 - EX-99.1 EX-99.1
• 11.06.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 10.17.2025 - S-3 Registration statement under Securities Act of 1933
• 10.15.2025 - 8-K Current report
• 09.24.2025 - 4 Statement of changes in beneficial ownership of securities
• 09.17.2025 - 1-A-W Withdrawal of offering statement [Regulation A]
• 09.05.2025 - EFFECT Notice of Effectiveness
• 09.05.2025 - 424B3 Prospectus [Rule 424(b)(3)]
• 08.29.2025 - S-3 Registration statement under Securities Act of 1933